AbCellera Biologics Inc.
Panjang
Telah dikemas kini

$ABCL – Loaded Base Pattern Forming

173
Entry: $3.90
Stop: $3.50
Target: $4.50–5.00
Status: Active swing, scaling in at Darvas box lows
System: Seed System v2.1 | EMA stack | VWMA confluence | RSI/Volume triggers

ABCL is riding a tight compression zone just above VWMA with layered Darvas box support. Multiple Seed System entries triggered this week, each followed by fast moves of 4–10%. Recent stop-outs have been shallow, suggesting accumulation.

Today’s candle shows continuation with a bullish MACD curl and volume pulse — watching for breakout above $4.10 with room to $4.50+ short-term.

Risk remains defined under $3.50, and I’ll reassess if the VWMA fails.

The Seed System identifies setup strength by syncing Darvas ranges with EMA/VWMA directionality and volume conviction. This one's been pinging repeatedly — the coil is tightening.

#ABCL #SeedSystem #SwingTrade #BiotechStocks #DarvasBox #MACD #VWMA #EMAStack #VolumeSetup
Dagangan aktif


ABCL Update – Holding Long Shares + $5 Calls

ABCL broke out cleanly above the $4.25 base with strong volume and has since consolidated into a new range between $4.38 and $4.51. Price is currently hovering near the VWMA, showing signs of healthy digestion rather than rejection.

I’m holding long from the breakout and added $5 call options at $0.35 premium as a speculative swing. My plan is to ride the momentum if we push through $4.51 with volume, scaling the options if we hit $4.75–$5+. If we drop below $4.38, I’ll monitor closely for signs of weakness. A break under $4.25 invalidates the setup, and I’ll be out.

MACD just crossed bearish, but histogram remains elevated, suggesting we might just be cooling off before another move. No panic yet—volume is quiet, not distributive.

This is a dual-layer trade: shares for structure, calls for velocity. Staying patient and letting price prove the next move.

The Seed System thrives on preparation, not prediction.

Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.